RxDoctor Payments Data

David Arnold, MD

Family Medicine · Geneva, ALNPI 1891794822

Payments from drug & device makers

$533in general payments, 2019–2025

Across 25 payments — averaging $21.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$213
  • Medtronic$81
  • AstraZeneca$65
  • Abbott$39
  • Merck$35
  • Otsuka America Pharmaceutical, Inc.$22
  • plus $77 from 5 others

What the payments were for

  • Food & beverage$533100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$533 in reported general payments places this provider in the 45th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$2,877
Medicare patients
99
Services billed
255

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide97$112,899
JanuviaSitagliptin Phosphate100$107,037
MounjaroTirzepatide64$82,536
JardianceEmpagliflozin70$66,473
XareltoRivaroxaban35$46,834
FarxigaDapagliflozin Propanediol32$43,908
EliquisApixaban50$41,132
RybelsusSemaglutide20$40,343
TrulicityDulaglutide14$31,786
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$17,441
Spiriva RespimatTiotropium Bromide25$16,977
LinzessLinaclotide11$9,375
SymbicortBudesonide/Formoterol Fumarate16$7,383
Lantus SolostarInsulin Glargine,hum.Rec.Anlog41$7,379
Naproxen29$6,869

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$16$114,32378 claims
MerckJanuvia$35$107,037100 claims
AstraZenecaFarxiga, Symbicort$65$51,29048 claims
Johnson & JohnsonXarelto$16$46,83435 claims
PfizerEliquis$17$41,13250 claims
AbbVieLinzess$213$9,37511 claims
Almatica Pharma LLCSertraline Hcl$14$1,630170 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Geneva

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →